ArticleFrontiers in oncology2022

Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response.

Amisha Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.